US The Pfizer vaccine soon authorized for 12-15 years in the United States
From scarcity to abundance: US faces calls to share vaccines
TEGUCIGALPA, Honduras (AP) — Victor Guevara knows people his age have been vaccinated against COVID-19 in many countries. His own relatives in Houston have been inoculated. But the 72-year-old Honduran lawyer, like so many others in his country, is still waiting. And increasingly, he is wondering why the United States is not doing more to help, particularly as the American vaccine supply begins to outpace demand and doses that have been approved for use elsewhere in the world, but not in the U.S., sit idle. “We live in a state of defenselessness on every level,” Guevara said of the situation in his Central American homeland.
The extension of vaccination to this age group could increase the level of collective immunity in the country.
The United States should authorize the Pfizer-Biontech vaccine against CVIV-19 for children over 12 years from next week, according to American media.
According tochain, Pfizer requested an emergency authorization for its vaccine for children aged 12 to 15 years. Citing a government official, CNN explained that the US Food and Medicinal Product Agency (FDA) will have to change its regulation on vaccine emergency authorization. A pretty simple process, according to him.
The Big Pharma CEO Who's Helping to Put an End to COVID-19
In developing its vaccine, Pfizer was doing what the private sector does best: thrive under pressure and respond to market demands as no government agency can. "[Bourla] laid out early why it was so important to put up the enormous resources of Pfizer without an eye toward the business bottom line," Dr. Scott Gottlieb, former head of the Food and Drug Administration (FDA) and a director at Pfizer, told Forbes. "Coming up with a vaccine could change the course of human history."History is being changed thanks to Pfizer, along with Johnson & Johnson and Moderna.
On the other hand, it specifies that extending it to the youngest children would not be so easy:
"For children over 12 years old, if nothing exceptional is detected, if everything seems the same as for adults, I think it is not necessary to organize an advisory committee meeting. For younger children, it will certainly be necessary to consider it.
In the United States,conclusive clinical trials, according to Pfizer for all persons aged 16 and over. If extended to teenagers, the vaccination campaign could affect millions of additional people.
according to, vaccinating children is the key to increasing the level of immunity from the population and therefore reduce the number of hospitalizations and deaths due to VVID- 19. This authorization would therefore be a "big step for the vaccination campaign and a new welcome for anxious parents, who want to protect their children this summer during the holidays and before the start of next September," explains the newspaper.
Vaccines aplenty but some Californians struggle to get one
SAN FRANCISCO (AP) — Hearing of excess vaccine and unfilled appointments frustrates Dr. Aaron Roland, a family physician who has been lobbying for doses to inoculate his patients, many of whom are low-income, immigrants or elderly. The San Francisco Bay Area doctor has more than 200 patients who have inquired when he will offer inoculations against the coronavirus. One patient, who is 67, said he walked into a Safeway supermarket because signs said doses were available.
45% of adults not yet vaccinated , the Pfizer laboratory stated that clinical trials had shown that the vaccine was safe and produced solid antibodies in 12-15 years. The preliminary results of the published study at the end of March by Pfizer, and conducted with 2,260 US volunteers aged 12 to 15, have shown that there were no CVIV-19 cases among fully vaccinated adolescents, Against eighteen among those who received dummy injections. Children had similar side effects to young adults, said the laboratory. The main adverse effects are pain, fever, chills and fatigue, especially after the second dose.
According to official data, the vaccination rate in the United States has reached its peak around April 11, and although 55% of adults have now received one or more doses, the way to go To achieve collective immunity is still long, explains AFP.
Full FDA approval of Covid-19 vaccines could help fight vaccine hesitancy, officials say
As a condition of the emergency use authorizations issued for the Pfizer/BioNTech and Moderna coronavirus vaccines, those companies are expected to work toward asking the US Food and Drug Administration for full approval -- and some health officials are hoping it will happen soon. © Chandan Khanna/AFP/Getty Images Healthcare worker Caryn Blair (R) administers a Covid-19 vaccine to Nicolas Gonzalez Marcelino at Florida Memorial University Vaccination Site in Miami Gardens, Florida on April 14, 2021. - Florida Division of Emergency Management has opened a new permanent vaccination site at Florida Memorial University.
Among Republican voters, 29% say they will never be vaccinated, compared to 5% of the Democrats and 9% of the self-employed, according to a recent survey of Kaiser Family Foundation.
Europe also thinksto teenagers. The European Medicines Agency (EMA) has started its 12-15 year assessment. "The EMA will communicate the results [...], expected in June, unless other information is needed," she said on May 3.
Also on MSN - Covid-19: Olivier Véran Assures that France will continue to vaccinate with Johnson and Johnson
Pfizer-BioNTech seeks full FDA approval for COVID-19 vaccine .
Like other vaccines available in the U.S., Pfizer-BioNTech have been providing their vaccine under an emergency use authorization.They announced that they will be submitting data to the FDA on a rolling basis over the coming weeks, with a request for priority review. It's not clear how long that review will take.